posted
Looks like we're back in above .04, barely! But maybe it will keep on chugging...
Posts: 255 | From: Charlottesville, VA | Registered: Feb 2005
| IP: Logged |
posted
Lets not forget the lucrative business that CLBE is in..
About CalbaTech
CalbaTech is focused on developing and providing products and platforms to the research market, both for biotech and pharmaceutical companies, as well as academic institutions. In addition to growth through acquisition, CalbaTech, comprised of three divisions, Molecular Applications, Research Reagents, and Cellular Therapeutics, is building an experienced and innovative scientific staff, including several notable members of its Scientific Advisory Board that intend to contribute innovation in areas of biological discovery.
Posts: 79 | From: California | Registered: Sep 2005
| IP: Logged |
posted
CalbaTech's Subsidiary, LifeStem, Inc., Selects Leading Physician as Chief Medical Officer 11/22/2005
IRVINE, Calif., Nov 22, 2005 /PRNewswire-FirstCall via COMTEX/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced today that its wholly owned subsidiary LifeStem, Inc., has selected Dr. Jason R. Van Tassel as its Chief Medical Officer.
Los Angeles based physician, Dr. Jason R. Van Tassel M.D., was selected to become LifeStem's Chief Medical Officer. In this new position, Dr. Van Tassel will direct all of the company's medical technologies related to its Stem Cell MicroBank service and provide advisory, consulting and technical services to the company. He will also be directly involved in the rollout of LifeStem's MicroBanking Stem Cell collection and storage service with Solana MedSpas which the company announced on November 17th.
"We're very fortunate to have Dr. Van Tassel as part of our management team," said LifeStem President Dan Fulkerson. "Dr. Van Tassel has been with our parent company, CalbaTech, as an advisory board member for the past year so he knows our business and as is well qualified to fill this important role," Mr. Fulkerson added.
According to Dr. Van Tassel, the timing of his appointment was ideal. "The stem cell market is quickly expanding and the benefits of adult stem cells as a regenerative therapy are rapidly becoming evident. With the addition of the Solana MedSpa network, I am convinced that LifeStem's MicroBank service will be an essential component to an overall stem cell therapy."
Dr. Van Tassel is currently in medical practice specializing in Otolaryngology, Facial Plastic and Reconstructive Surgery in Los Angeles, CA. Dr. Van Tassel attended Georgetown University School of Medicine in Washington D.C., graduating with Honors in 1997. Upon completion of his residency, Dr. Van Tassel joined the faculty at the University of California at Irvine in the Department of Facial Plastic and Reconstructive Surgery, completing a fellowship in 2003. He is currently board certified in Otolaryngology and board eligible in Facial Plastic and Reconstructive Surgery. He is an Associate Clinical Professor at UCLA in the Department of Surgery, in the Division of Otolaryngology Head and Neck Surgery. Prior to practicing medicine in Los Angeles, Dr. Van Tassel worked at Hybritech Inc., a subsidiary of Eli Lilly, where he performed research investigating manufacturing processes related to monoclonal antibody test assays. In addition, Dr. Van Tassel also investigated retinal signal transduction pathways for the Dept. of Neurosciences at San Diego State University.
-------------------- Trading is a blast!! Posts: 4921 | From: Rhode Island | Registered: May 2005
| IP: Logged |
posted
I finally played this right. Was in at .049 and out at .057 today on the run. This thing seems like it always returns to lower levels again. I will buy in again if we hit the low 40s or even 30s and do it again... no more holding through these spikes unless we get BIG news.
Posts: 112 | From: Syracuse, NY | Registered: Oct 2005
| IP: Logged |
posted
I got a hat trick going on CLBE. I have bought 100k at .033 three times in the last 6 weeks and sold between .042 and .048, may have missed out on some upside, but it's been nice dependable cashflow. So there you have it, look for .033!!
-------------------- I may be wrong, but I don't think so.... Posts: 837 | From: Madison, WI | Registered: Sep 2005
| IP: Logged |
posted
thats what trading is all about but on good companies I don't like unloading totally,playing will half is a little safer since sooner or later there will be no or very little retrace.
posted
am i the only one that didnt sell (I wish i did but a lot happened while i was away for two hours) any thought on where this might be tommorow?
Posts: 105 | From: canada | Registered: Sep 2005
| IP: Logged |
The market for stem cell technology is currently $500 million, and has been estimated to grow to $30 billion by the year 2010 due to the growth of new cellular therapeutics as well as clinical applications. LifeStem's strategy is to leverage CalbaTech's infrastructure of companies to obtain a leadership position in the emerging stem cells arena and become a preferred provider of adult stem cells to the clinical researcher as part of a comprehensive package of stem cell based services.
The one thing about high quality penny stocks is that they rarely ever run high and fast at the same time. Most are slow growth but strong investments to certain levels. As science progress anyone can see that stem cell technology is going to be a major contributor but many here may believe that is all CalbaTech does and that’s not true. They are really deep into DNA and molecular research also.
Posts: 79 | From: California | Registered: Sep 2005
| IP: Logged |
posted
keep an eye on this one now until the end of year.
from the most recent 10K, thought I'd share some of my favorite quotes that makes a good reminder.
1. "The company believes that it will report a net profit for 2005."
2. Regarding LifeStem's stem cell banking service: "It is not unreasonable to project potential revenues approaching $100 Million within 36 to 48 months with as few as 10,000 clients."
3. Officers and Directors:
James DeOlden, Esq. -- CEO: B.A. from UVA, J.D. from Whittier Law School, he has a securities law practice.
Edward Deese -- President, COO: B.S. in Economics from University of California, Irvine.
John Gordon, Ph.D. -- CTO: B.Sc. Honors in Cell Biology, Ph.D. from University of Glasgow.
4. Scientific Advisory Board:
Kary B. Mullis: Recieved the 1993 Nobel Prize in chemistry for his invention of the polymerase chain reaction (PCR). Ph.D. from Berkeley, B.S. from Georgia Institute of Technology.
Basically, the company looks like it's going to be profitable soon and the directors and advisors appear to be very intelligent people who are leaders in their respective fields.
posted
Pretty quite 'round these parts. Is there a newer thread for CLBE or has discussion just run dry since the company hasn't released any PR lately?
Quest, et al.:
CLBE and PMEd have sunk by nearly 50% since I bought 'em a while back... I'm still pretty confident they'll go back up (especially CLBE, at this point), but will we actually see a 100%+ run in the near future for either of 'em, I wonder, or should I unload before 2006, so I can write it all off as losses?
posted
I still believe in this company 100%! I'm not happy about the price, but in my opinion, she'll turn around soon! I'd like to hear Quests comments on this one too though!
-------------------- "As long as there are dreamers, there are dreams that will come true." Posts: 862 | From: CT Yankee..... in FLA | Registered: Aug 2005
| IP: Logged |
posted
At 0.033 it's a great time to add a new position. The chart shows it moves with cycle and it will be in the 0.05s next week. This dip is part of the MMs' game plan to collect cheap shares. Wait and see.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
I bought a chunk at 0.034 this morning, which has allowed me to average down to the low 5s, finally... It feels good not to see that negative 55% on my chart anymore, even though I'm still in the red. Of course, just my luck that CLBE seems to now be dropping even lower than the 0.034 I thought would be the support, but if JimSC's chart prediction is correct then I'll be back above break-even by next week...
Good luck to all!
Posts: 249 | From: NYC | Registered: Sep 2005
| IP: Logged |
posted
If you understand the MMs' agenda, you will be more confortable with the dips, when they bring down the pps to collect cheap shares. After they collect enough, they wil raise the pps. Just wait and see.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
I'm still holding and averaging down also for whatever that's worth! I watched the MM's do exactly what JimSC is talking about with MBAH sveral times so I just ride the wave with them!
Posts: 255 | From: Charlottesville, VA | Registered: Feb 2005
| IP: Logged |
posted
Hey, Tooka56, sooner or later you might become an assistant to the MMs. Good luck on your riding the waves with the MMs. JimSc
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
This is part of the MMs game plan -- creating feat to get cheap shares. I will buy more.
******** Buy when the MMs are buying and sell when the MMs are selling. imho ******** The MMs have tons of inventory between 0.032 to 0.038 from last few cycles; they are preparing for a long rally for this stock, so they want to get more by lowering the pps. So hold your shares tight. When they finish collecting, they will raise the pps to unload their inventory to the investors. Check the charts, and you will find their tricks and take advantage of them.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
When O/S get to 97 million you will know dilution is over as far as their toxic financing... then it should pop, but until then just trade it...
quote:Originally posted by iiiqqqeg: SCHB dilluting?
I have a hot tip from a friend that works with biotech companies. Notice the abnormal clbe volume? Expect a major PR concerning their patents either tomorrow or thursday the latest. My advice is to be in this before close tomorrow otherwise you will be stuck chasing. The pr is expected to be overwhelmingly positive with several biotech companies showing interest in clbes patent. I have a set buy to buy 1 million shares of clbe at .03 tomorrow. That's how confident I am in this. If it doesn't fill I'm just going to grab whatever I can at whatever price it is at.
From my source the conservative estimate is ten cents by friday, THATS RIGHT TEN CENTS! And continuing higher next week. POSITIVE PATENT NEWS IS HUGE!
Posts: 1 | Registered: Dec 2005
| IP: Logged |
posted
This thing is a steal at these levels... If there is a chance to buy around .03 tomorrow, it won't be for long.
Posts: 112 | From: Syracuse, NY | Registered: Oct 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
![[Wink]](wink.gif)
![[Roll Eyes]](rolleyes.gif)
![[Confused]](confused.gif)
![[Smile]](smile.gif)
